• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Katz webinar on XMRV Coming up on Thursday

dannybex

Senior Member
Messages
3,564
Location
Seattle
But if I'm not mistaken, the majority of patients will still need to wait for an FDA-approved, government-validated test, before we get any financial coverage for this - or wider acceptance by less-informed physicians, of the test as "legit". Which underscores the importance of advocacy to educate the blood folks and other stakeholders on WHY this is urgent - from a scientific perspective.

And of course we have to wait for causality research. And the media response to XMRV - when embargos are finally lifted - may change the way things unfold.

That should definitely help...but yes, I would think nothing will be covered until both causality can be proven, and an FDA approved test is available.
 

LJS

Luke
Messages
213
Location
East Coast, USA
I found these two slides very interesting, it looks like the CDC has the most sensitive test. This raises the question; why did the CDC find all of the 20 positive control samples sent from the WPI negative? We know why they did not find any positives in their study due to poor patient selection.
 

Attachments

  • test_panel_slide&#9.jpg
    test_panel_slide&#9.jpg
    64.5 KB · Views: 22
  • test_panel_slide&#9.jpg
    test_panel_slide&#9.jpg
    91.2 KB · Views: 18

George

waitin' fer rabbits
Messages
853
Location
South Texas
I found these two slides very interesting, it looks like the CDC has the most sensitive test. This raises the question; why did not they find any of the 20 sampled sent from the WPI positive? We know why did didn't find any positives in there study due to poor patient selection.

My guess is diffrent people working in diffrent labs with diffrent agendas. But that's just a guess.
 

Cort

Phoenix Rising Founder
At least a year until a CLINICAL assay is ready for XMRV diagnostics?
Dr Katz gave a preliminary answer to one of my earlier questions about the process to translate analytical assays to clinical assays. As I recall, he initially said one year, then he gave more info on West Nile, said it took THEM a year, and that because XMRV was currently perceived with less urgency, it could take longer for us.

Can anyone answer any of the following questions I asked in the Amy Dockser Marcus thread: http://www.forums.aboutmecfs.org/sh...XMRV-Working-Group-Report&p=105519#post105519


Fostering a sense of urgency for availability of clinical tests for XMRV
Which raises my final question: What can we do to impress on the blood folks and other key stakeholders, the urgency for patients with ME/CFS to have diagnostics and clinical trials asap (in the event XMRV is found to be causal)? Which agencies/key contacts should we be directing educational/advocacy letters to?


I hope he's wrong about that 12 months! I can't imagine that is right. The WPI, I believe, has a patent on antibody tests and we've heard that Dr. Singh and other labs are working on one. Coffin thought we'd know about XMRV in about six months give or take and we're about there. Kim said 20 data presentation on XMRV in Sept - that's alot of new work! Things are happening. I think we'll at least have some pretty important answers over the next couple of months.